N/A
N=221
Outlook Quality of Life Intervention Study
Cancer · Congestive Heart Failure (CHF) · Chronic Obstructive Pulmonary Disease (COPD) · End Stage Renal Disease (ESRD)
Bottom Line
View on ClinicalTrials.gov: NCT01044290 ↗Enrolled (actual)
221
Serious AEs
18.6%
Results posted
Oct 2015
Primary outcome: Primary: QUAL-E - Preparation Sub-scale — 15.7; 14.5; 14.8; 16.0 units on a scale — p=<0.61
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Life Completion (Other); Attention Control (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Feb 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY QUAL-E - Preparation Sub-scale |
15.7; 14.5; 14.8; 16.0; 15.5; 14.4 | <0.61 |
| PRIMARY QUAL-E Life Completion Sub-scale |
26.0; 26.4; 25.8; 26.6; 26.4; 25.6 | .25 |
| SECONDARY POMS Anxiety Sub-scale |
5.5; 5.9; 6.5; 5.4; 5.6; 5.9 | =.9 |
| SECONDARY CES-D |
7.9; 8.9; 9.4; 8.1; 8.4; 9.2 | <.91 |
| SECONDARY FACIT-SP |
34.5; 33.6; 32.8; 34.6; 33.8; 33.9 | =.58 |
| SECONDARY FACT-G - Social Sub-scale |
18.0; 17.4; 17.4; 18.4; 17.6; 17.1 | <.57 |
Summary
The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.
Eligibility Criteria
Inclusion Criteria
- Patients with
- Advanced cancer
- Congestive heart failure
- COPD
- End stage renal disease
Exclusion Criteria
- Cognitive impairment
- inability to speak
- non-English speaking
Data sourced from ClinicalTrials.gov (NCT01044290). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.